Anti-FOXO3A (phospho S253) antibody (ab47285)

Publishing research using ab47285? Please let us know so that we can cite the reference in this datasheet.

ab47285 has been referenced in 6 publications.

  • Holloway TM  et al. High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats. PLoS One 10:e0121138 (2015). WB ; Rat . PubMed: 25803693
  • Fiskus W  et al. Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells. Mol Cancer Ther 12:577-88 (2013). PubMed: 23445613
  • Fiskus W  et al. Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells. Clin Cancer Res 17:7347-58 (2011). WB ; Human . PubMed: 21976548
  • Liang R  et al. Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice. Aging Cell 10:1080-8 (2011). PubMed: 21967153
  • Jones A  et al. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 151:3706-19 (2010). WB ; Mouse . PubMed: 20534726
  • Sáinz N  et al. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One 4:e6808 (2009). WB, IHC-P ; Mouse . PubMed: 19730740

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"